Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C Lea

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Technology in Cancer Research & Treatment|September 12, 2008
AKT1 (E17K) mutation in pancreatic cancerAzim Mohamedali, Nicholas C Lea, Roger M Feakins, et al.
Journal of Biochemical and Biophysical Methods|April 23, 2003
High efficiency protein transduction of quiescent and proliferating primary hematopoietic cellsNicholas C Lea, Andrea G S Buggins, Stephen J Orr, et al.
Haematologica|May 2, 2009
Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromesTerry J Gaymes, Sydney Shall, Lee J MacPherson, et al.
Haematologica|August 2, 2021
Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromesTerry J Gaymes, Sydney Shall, Lee J Macpherson, et al.
Journal of Leukocyte Biology|November 13, 2003
Cyclin D2 controls B cell progenitor numbersAzim Mohamedali, Inês Soeiro, Nicholas C Lea, et al.
Genome Research|June 24, 2009
Epigenetics of human T cells during the G0-->G1 transitionAlexander E Smith, Constantinos Chronis, Manolis Christodoulakis, et al.
Molecular and Cellular Biology|March 18, 2003
Commitment point during G0-->G1 that controls entry into the cell cycleNicholas C Lea, Stephen J Orr, Kai Stoeber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2009
Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndromeAzim M Mohamedali, Alexander E Smith, Joop Gaken, et al.
Haematologica|January 10, 2013
Spliceosome mutations exhibit specific associations with epigenetic modifiers and proto-oncogenes mutated in myelodysplastic syndromeSyed A Mian, Alexander E Smith, Austin G Kulasekararaj, et al.
Molecular Systems Biology|March 15, 2012
Proteomic and protein interaction network analysis of human T lymphocytes during cell-cycle entryStephen J Orr, Daniel R Boutz, Rong Wang, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Technology in Cancer Research & Treatment|September 12, 2008
AKT1 (E17K) mutation in pancreatic cancerAzim Mohamedali, Nicholas C Lea, Roger M Feakins, et al.
Journal of Biochemical and Biophysical Methods|April 23, 2003
High efficiency protein transduction of quiescent and proliferating primary hematopoietic cellsNicholas C Lea, Andrea G S Buggins, Stephen J Orr, et al.
Haematologica|May 2, 2009
Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromesTerry J Gaymes, Sydney Shall, Lee J MacPherson, et al.
Haematologica|August 2, 2021
Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromesTerry J Gaymes, Sydney Shall, Lee J Macpherson, et al.
Journal of Leukocyte Biology|November 13, 2003
Cyclin D2 controls B cell progenitor numbersAzim Mohamedali, Inês Soeiro, Nicholas C Lea, et al.
Genome Research|June 24, 2009
Epigenetics of human T cells during the G0-->G1 transitionAlexander E Smith, Constantinos Chronis, Manolis Christodoulakis, et al.
Molecular and Cellular Biology|March 18, 2003
Commitment point during G0-->G1 that controls entry into the cell cycleNicholas C Lea, Stephen J Orr, Kai Stoeber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2009
Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndromeAzim M Mohamedali, Alexander E Smith, Joop Gaken, et al.
Haematologica|January 10, 2013
Spliceosome mutations exhibit specific associations with epigenetic modifiers and proto-oncogenes mutated in myelodysplastic syndromeSyed A Mian, Alexander E Smith, Austin G Kulasekararaj, et al.
Molecular Systems Biology|March 15, 2012
Proteomic and protein interaction network analysis of human T lymphocytes during cell-cycle entryStephen J Orr, Daniel R Boutz, Rong Wang, et al.
Pageof 2